Advertisement

Drugs & Aging

, Volume 7, Issue 6, pp 459–479 | Cite as

Cognitive Impairment in Elderly People

Predisposing Factors and Implications for Experimental Drug Studies
  • J. Jolles
  • F. R. J. Verhey
  • W. J. Riedel
  • P. J. Houx
Epidemiology

Summary

The consequences for cognitive functioning of normal aging, depression and dementia are well known. However, the borderline between normal and pathological cognitive aging is less well understood. Recently, it has been found that it is important to differentiate between ‘successful’, ‘usual’ and pathological cognitive aging. This article reviews existing views on this borderline.

Recently, it has been found that health-related factors, or biological life events, may determine the rate of cognitive aging. Various different, but similar, diagnostic descriptions of age-related cognitive dysfunction exist simultaneously: benign senescent forgetfulness, malignant senescent forgetfulness, age-associated memory impairment, age-consistent memory impairment, late-life forgetfulness, mild cognitive changes (subthreshold) and cognitive impairment disorders are some examples of different diagnostic categories. There are also various diagnostic tools to obtain these experimental diagnoses; for example, the Global Deterioration Scale, the Clinical Dementia Rating Scale and the Cambridge Mental Disorders of the Elderly Examination. A diagnosis is considered important for the early detection of dementia.

Pharmacological treatments are still in the experimental stage. Improvement of cognitive function has particularly been studied in clinical trials with groups of patients with Alzheimer’s disease as well as patient groups with age-associated memory impairment. Future strategies may orient more towards treating symptoms of cognitive dysfunction, probably also on the basis of diagnosis of health-related factors, in age-related cognitive decline and depression.

Keywords

Dementia Cognitive Aging Mild Dementia Oxiracetam Global Deterioration Scale 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jolles J. Cognitive, emotional and behavioral dysfunctions in aging and dementia. In: Swaab DF, Fliers E, Mirmirian M, et al., editors. Progress in brain research. Amsterdam: Elsevier Science Publishers, 1986; 70: 15–39PubMedGoogle Scholar
  2. 2.
    Birren JE, Warner Schaie K, editors. Handbook of the psychology of aging. 3rd ed. New York: Van Nostrand Reinhold Company, 1990Google Scholar
  3. 3.
    Botwinick J. Aging and behavior. 3rd ed. New York: Springer, 1984Google Scholar
  4. 4.
    Charness N, editor. Aging and human performance. Chichester: John Wiley & Sons, 1985Google Scholar
  5. 5.
    Salthouse TA. Speed of behavior and its implications for cognition. In: Birren JE, Schaie KW, editors. Handbook of the psychology of aging. New York: Van Nostrand Reinhold, 1985: 400–26Google Scholar
  6. 6.
    Masur DM, Sliwinski M, Lipton RB, et al. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427–32PubMedGoogle Scholar
  7. 7.
    Ban TA. Psychopharmacology and successful cerebral aging. Prog Neuropsych Biol Psychiatry 1994; 19: 1–9Google Scholar
  8. 8.
    Michel B, Sambuc R, Scotto JC. French recommendations for clinical drug trials in cognitive disorders of the elderly. Int J Geriatr Psychiatry 1994; 9(10): 823–28Google Scholar
  9. 9.
    O’Brien JT, Levy R. Age associated memory impairment. BMJ 1992; 304: 5–6PubMedGoogle Scholar
  10. 10.
    Verhey FRJ, Jolies J, Ponds RWHM, et al. Diagnosing dementia: comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci 1993; 5(1): 78–85PubMedGoogle Scholar
  11. 11.
    Huppert FA. Age-related changes in memory: learning and remembering new information. In: Boiler F, Grafman J, editors. Handbook of neuropsychology. Amsterdam: Elsevier Science Publishers, 1991: 123–47Google Scholar
  12. 12.
    LaRue A. Aging and neuropsychological assessment. New York: Plenum Press, 1992Google Scholar
  13. 13.
    Huppert FA, Tym E. Clinical and neuropsychological assessment of dementia. Br Med Bull 1986; 42: 11–8PubMedGoogle Scholar
  14. 14.
    Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Neurology 1989; 39: 1159–65PubMedGoogle Scholar
  15. 15.
    Storandt M, Botwinick J, Danziger WL, et al. Psychometric differentiation of mild dementia of the Alzheimer type. Arch Neurol 1984; 41: 497–9PubMedGoogle Scholar
  16. 16.
    Amaducci L, Angst J, Bech P, et al. Consensus conference on the methodology of clinical trials of ‘nootropics’; 1989 Jun 28–30: Munich. Report of the consensus committee. Pharmacopsychiatry, 1990; 23(4): 171–5PubMedGoogle Scholar
  17. 17.
    Gray JA, Enz A, Spiegel R. Muscarinic agonists for senile dementia: past experience and future trends. Trends Pharmacol Sci 1989; 10: 85–8Google Scholar
  18. 18.
    Thal LJ. Clinical trials in Alzheimer’s disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer’s disease. New York: Raven Press, 1994: 431–44Google Scholar
  19. 19.
    Whalley LJ. Drug treatments of dementia. Br J Psychiatry 1989; 155: 595–611PubMedGoogle Scholar
  20. 20.
    Riedel WJ, Jolies J. Cognition enhancers in age-related cognitive decline. Drugs Aging. In pressGoogle Scholar
  21. 21.
    Birren JE, Warner Schaie K, editors. Handbook of the psychology of aging. 2nd ed. New York: Van Nostrand Reinhold Company, 1985Google Scholar
  22. 22.
    Reese HW, Rodeheaver D. Problem solving and decision making. In: Birren JE, Schaie KW, editors. Handbook of the psychology of aging. 2nd ed. New York: Van Nostrand Reinhold, 1985: 474–99Google Scholar
  23. 23.
    Plude DJ, Hoyer WJ. Attention and performance: identifying and localizing age deficits. In: Charness N, editor. Aging and human performance. Chichester: Wiley, 1985: 47–99Google Scholar
  24. 24.
    Woodruff DS. Arousal, sleep, and aging. In: Birren JE, Schaie KW, editors. Handbook of the psychology of aging, New York: Van Nostrand Reinhold, 1985: 261–95Google Scholar
  25. 25.
    Salthouse TA. Resource-reduction interpretations of cognitive aging. Dev Rev 1988; 8(3): 238–72Google Scholar
  26. 26.
    Houx PJ, Vreeling FW, Jolies J. Rigorous health screening reduces age effect on memory scanning task. Brain Cogn 1991; 15(2): 246–60PubMedGoogle Scholar
  27. 27.
    Rabbitt PMA. Applied cognitive gerontology: some problems, methodologies and data. Appl Cogn Psychol 1990; 4: 225–46Google Scholar
  28. 28.
    Haug H. Are neurons of the human cerebral cortex really lost during aging? In: Traber J. Gispen WH, editors. Senile dementia of the Alzheimer type. Berlin: Springer Verlag, 1985: 150–63Google Scholar
  29. 29.
    Riegel KF, Riegel RM. A study of the drop-out rates in longitudinal research on aging and the prediction of death. J Pers Soc Psychol 1967; 4: 342–8Google Scholar
  30. 30.
    Riegel KF, Riegel RM. Development, drop, and death. Dev Psychol 1972; 6: 309–16Google Scholar
  31. 31.
    Houx PJ, Vreeling FW, Jolies J. Stroop interference: aging effects assessed with the Stroop Color-Word Test. Exp Aging Res 1993; 19: 209–24PubMedGoogle Scholar
  32. 32.
    Jolies J, Houx PJ, Vreeling FW, et al. Cognitive aging, biological life events and primitive reflexes. Neurosci Res Commun 1994; 13 Suppl. 1: S47–S50Google Scholar
  33. 33.
    Rabbitt PMA, Goward LM. Effects of age and raw IQ test scores on mean correct and mean error reaction times in serial choice tasks: a reply to Smith & Brewer. Br J Psychol 1986; 77(1): 69–73Google Scholar
  34. 34.
    Geffen G, Moar KJ, O’Hanlon AP, et al. Performance measures of 16- to 86-year-old males and females on the auditory verbal learning test. Clin Neuropsychologist 1990; 4(1): 45–63Google Scholar
  35. 35.
    Verillo RT, Verillo V. Sensory and perceptual performance. In: Charness N, editor. Aging and human performance. Chichester: Wiley, 1985: 1–46Google Scholar
  36. 36.
    Stones MJ, Kozma A. Physical performance. In: Charness N, editor. Aging and human performance, Chichester: Wiley, 1985: 261–91Google Scholar
  37. 37.
    Houx PJ, Jolies J. Vulnerability factors for age-related cognitive decline. In: Isaacson RL, Jensen KF, editors. The vulnerable brain and environmental risks. New York: Plenum Press, 1994: 25–41Google Scholar
  38. 38.
    Houx PJ, Vreeling FW, Jolies J. Age-associated cognitive decline is related to biological life events. In: Iqbal K, McLachlan DRC, Winblad B, et al., editors. Alzheimer’s disease: basic mechanisms, diagnosis and therapeutic strategies. Chichester: John Wiley & Sons Ltd, 1991: 353–9Google Scholar
  39. 39.
    Houx PJ, Jolies J. Age-related decline of psychomotor speed: effects of age, brain health, sex and education. Percept Mot Skills 1993; 76: 195–211PubMedGoogle Scholar
  40. 40.
    Vreeling FW, Jolies J, Verhey FRJ, et al. Primitive reflexes in Alzheimer’s disease and vascular dementia. J Geriatr Psychiatry Neurol 1995; 8(2): 111–7PubMedGoogle Scholar
  41. 41.
    Fozard JL, Metter EJ, Brant LJ. Next steps in describing aging and disease in longitudinal studies. J Gerontol 1990; 43(4): 116–27Google Scholar
  42. 42.
    Colsher PL, Wallace RB. Epidemiologic considerations in studies of cognitive function in the elderly: methodology and non-dementing acquired dysfunction. Epidemiol Rev 1991; 13(1): 1–27PubMedGoogle Scholar
  43. 43.
    Haxby JV, Grady CL, Duara R, et al. Relations among age, visual memory, and resting cerebral metabolism in 40 healthy men. Brain Cogn 1986; 5: 412–27PubMedGoogle Scholar
  44. 44.
    Christensen KJ, Moye J, Armson RR, et al. Health screening and random recruitment for cognitive aging research. Psychol Aging 1992; 7: 204–8PubMedGoogle Scholar
  45. 45.
    Elias MF, Robbins MA, Schultz NR, et al. Is blood pressure an important variable in research on aging and neuropsychological test performance? J Gerontol 1990; 45(4): 128–35Google Scholar
  46. 46.
    Hartman DE. Neuropsychological toxicology: identification and assessment of human neurotoxic syndromes. New York: Pergamom Press, 1988Google Scholar
  47. 47.
    Hijman R, Jolies J, Verhoeven WMA, et al. Desglycinamide-(Arg(8))-vasopressin in five trials with memory-disturbed patients. Hum Psychopharmacol 1992; 7(1): 7–23Google Scholar
  48. 48.
    Rowe JW, Kahn RL. Human aging: usual and successful. Science 1987; 237: 143–9PubMedGoogle Scholar
  49. 49.
    Stones MJ, Kozma A, Hannah TE. The measurement of individual differences in aging: the distinction between usual and successful aging. In: Howe ML, Stones MJ, Brainerd CJ, editors. Cognitive and behavioral performance factors in atypical aging. New York: Springer Verlag, 1990: 181–218Google Scholar
  50. 50.
    Kay D, Bergmann K, Foster EM, et al. Mental illness and hospital usage in the elderly: a random sample followed up. Compr Psychiatry 1970; 11(l):26–35PubMedGoogle Scholar
  51. 51.
    Henderson AS, Huppert FA. The problem of mild dementia. Psychol Med 1984; 14:5–11PubMedGoogle Scholar
  52. 52.
    Henderson AS. The epidemiology of Alzheimer’s disease. Br Med Bull 1986; 42: 3–10PubMedGoogle Scholar
  53. 53.
    Freemon F. Evaluation of patients with progressive intellectual deterioration. Arch Neurol 1976; 33: 658–9PubMedGoogle Scholar
  54. 54.
    Hachinski V. Preventable dementia: a call for action against the vascular dementias. Lancet 1992; 340: 645–8PubMedGoogle Scholar
  55. 55.
    Marsden C, Harrison M. Outcome of investigation of patients with presenile dementia. BMJ 1972; 2(808): 249–52PubMedGoogle Scholar
  56. 56.
    Smith J, Kiloh L. The investigation of dementia: results in 200 consecutive admissions. Lancet 1981; ii: 824–7Google Scholar
  57. 57.
    Clarfield AM. The reversible dementias: do they reverse? Ann Intern Med 1988; 109: 476–86PubMedGoogle Scholar
  58. 58.
    Larson EB, Reifler BV, Sumi SM, et al. Diagnostic evaluation of 200 elderly outpatients with suspected dementia. J Gerontol 1985; 40: 536–43PubMedGoogle Scholar
  59. 59.
    Jolies J, Verhey FRJ. On the rationale behind treatment studies in cognitive aging and dementia. Paper presented at the Alzheimer’s Disease: back to the future. Amsterdam, 9 Oct 1992. Proceedings of the symposium on Alzheimer’s disease: recent advances in diagnosis and treatment. Amsterdam: Free University, 1993: 75–84Google Scholar
  60. 60.
    Commissaris CJAM, Verhey FRJ, Ponds RWHM, et al. Public education about normal forgetfulness and dementia: importance and effects. Patient Educ Couns 1994; 24: 109–15PubMedGoogle Scholar
  61. 61.
    Commissaris CJAM, Jolies J, Verhey FRJ, et al. Forgetfulness or dementia? Who is worried and why. Eur J Public Health 1995. In pressGoogle Scholar
  62. 62.
    Commissaris CJAM, Ponds RWHM, Verhey FRJ, et al. Public education about normal forgetfulness and dementia: effectiveness of a systematically developed information brochure. Educ Gerontol 1995; 21: 763–77Google Scholar
  63. 63.
    Philpot MP, Levy R. Memory clinic for the early diagnosis of dementia. Int J Geriatr Psychiatry 1987; 2: 195–200Google Scholar
  64. 64.
    Aevarsson O, Skoog I. Prodromal symptoms of dementia. Neurobiol Aging 1992; 13 Suppl.: 5LGoogle Scholar
  65. 65.
    Persson G, Berg S, Nilsson L, et al. Subclinical dementia. Relation to cognition, personality and psychopathology: a nine-year prospective study. Int J Geriatr Psychiatry 1991; 6: 239–47Google Scholar
  66. 66.
    Rubin EH, Kinscherf DA. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 1989; 146: 1017–21PubMedGoogle Scholar
  67. 67.
    Bozolla FG, Gorelick PB, Freels S. Personality changes in Alzheimer’s disease. Arch Neurol 1992; 49: 297–300Google Scholar
  68. 68.
    Chatterjee A, Strauss ME, Smyth KA, et al. Personality changes in Alzheimer’s disease. Arch Neurol 1992; 49: 486–91PubMedGoogle Scholar
  69. 69.
    Petry S, Cummings JL, Hill MA, et al. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988; 45: 1187–90PubMedGoogle Scholar
  70. 70.
    Rubin EH, Morris JC, Berg L. The progression of personality changes in patients with mild senile dementia of the Alzheimer type. J Am Geriatr Soc 1987; 35: 721–5PubMedGoogle Scholar
  71. 71.
    Bolla KI, Lindgren KN, Bonaccorsy C, et al. Memory complaints in older adults. Fact or fiction? Arch Neurol 1991; 48(1): 61–4PubMedGoogle Scholar
  72. 72.
    Christensen, H. The validity of memory complaints by elderly people. Int J Geriatr Psychiatry 1991; 6: 307–12Google Scholar
  73. 73.
    McGlone J, Gupta S, Humphrey D, et al. Screening for early dementia using memory complaints from patients and relatives. Arch Neurol 1990; 47: 1189–93PubMedGoogle Scholar
  74. 74.
    O’Brien JT, Beats B, Hill K, et al. Do subjective memory complaints precede dementia? A three year follow-up study of patients with supposed ‘benign senescent forgetfulness’. Int J Geriatr Psychiatry 1992; 7: 481–6Google Scholar
  75. 75.
    O’Connor DW, Pollitt PA, Roth M, et al. Memory complaints and impairment in normal, depressed and demented elderly persons identified in a community survey. Arch Gen Psychiatry 1990; 47: 224–7PubMedGoogle Scholar
  76. 76.
    Plotkin DA, Mintz JM, Jarvik LF. Subjective memory complaints in geriatric depression. Am J Psychiatry 1985; 142: 1103–5PubMedGoogle Scholar
  77. 77.
    Frederiks JAM. The neurology of aging and dementia. In: Bruyn D, editor. Handbook of clinical neurology. Amsterdam: Elsevier Science Publishers, 1985; 46: 199–219Google Scholar
  78. 78.
    Galasko D, Kwo-on-Yuen PF, Klauber MR, et al. Neurological findings in Alzheimer’s disease and normal aging. Arch Neurol 1990; 47: 625–7PubMedGoogle Scholar
  79. 79.
    Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type: 2. Psychometric test performance. Arch Neurol 1989; 46: 383–6PubMedGoogle Scholar
  80. 80.
    Rubin EH, Morris JC, Grant EA, et al. Very mild senile dementia of the Alzheimer type: 1. Clinical assessment. Arch Neurol 1989; 46: 379–82PubMedGoogle Scholar
  81. 81.
    Jobst KA, Smith AD, Szatmari M, et al. Detection in life of confirmed Alzheimer’s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992; 340: 1179–83PubMedGoogle Scholar
  82. 82.
    Weinstein H. SPECT in Alzheimer’s disease. Amsterdam: University Press, 1992Google Scholar
  83. 83.
    Scheltens P, Leys D, Barkhof F. Hippocampal atrophy on magnetic resonance imaging in Alzheimer’s disease and normal aging. Neurology 1991; 41 Suppl. 1: 341–2Google Scholar
  84. 84.
    Soininen HS, Partanen K, Pitkanen A, et al. Volumetric MRI analysis of the amygdala and the hippocampus in subjects with age-associated memory impairment: correlation to visual and verbal memory. Neurology 1994; 44(9): 1660–8PubMedGoogle Scholar
  85. 85.
    Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970; 126: 983–7PubMedGoogle Scholar
  86. 86.
    Verhey FRJ, Rozendaal N, Ponds RWHM, et al. Dementia, depression and awareness. Int J Geriatr Psychiatry 1993; 8: 851–6Google Scholar
  87. 87.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington DC: American Psychiatric Association, 1987Google Scholar
  88. 88.
    Chui HC, Teng EL, Henderson VW, et al. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35: 1544–50PubMedGoogle Scholar
  89. 89.
    McKhann G, Drachmann D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA workgroup under the auspices of the department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984; 34: 939–44PubMedGoogle Scholar
  90. 90.
    Román GC, Tatemichi TK, Erkinjuntii T, et al. Vascular dementia: diagnostic criterion for research studies. Report of the NINAIREN international workshop. Neurology 1993; 43: 250–60PubMedGoogle Scholar
  91. 91.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington D.C.: American Psychiatric Association, 1994Google Scholar
  92. 92.
    Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986; 149: 698–709PubMedGoogle Scholar
  93. 93.
    Hachinski V, Illif L, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32: 632–7PubMedGoogle Scholar
  94. 94.
    Rosen WG, Mohs RC. Evolution of cognitive decline in dementia. In: Corkin S, editor. Alzheimer’s disease: a report of progress. New York: Raven Press, 1982: 183–8Google Scholar
  95. 95.
    Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology 1992; 42: 473–80PubMedGoogle Scholar
  96. 96.
    Verhey FRJ, Lodder J, Rozendaal N, et al. Criteria for the clinical diagnosis of vascular dementia: a comparison between seven current sets. Neuroepidemiology. In pressGoogle Scholar
  97. 97.
    Kral VA. Neuro-psychiatric observations in an old people’s home. J Gerontol 1958; 13: 169–76PubMedGoogle Scholar
  98. 98.
    Reisberg B, Ferris SH, De Leon MJ, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139(9): 1136–9PubMedGoogle Scholar
  99. 99.
    Hughes CP, Berg L, Danziger WL, et al. A new rating scale for the staging of dementia. Br J Psychiatry 1982; 140: 566–72PubMedGoogle Scholar
  100. 100.
    Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health work group. Dev Neuropsychol 1986; 2(4): 261–76Google Scholar
  101. 101.
    Blackford RC, LaRue A. Criteria for diagnosing age-associated memory impairment: proposed improvements from the field. Dev Neuropsychol 1989; 5(4): 295–306Google Scholar
  102. 102.
    Caine ED. Should aging-associated cognitive decline be included in DSM-IV? J Neuropsychiatry Clin Neurosci 1993; 5(1): 1–5PubMedGoogle Scholar
  103. 103.
    Spitzer R, First MB, Williams JBW, et al. Now is the time to retire the term ‘organic mental disorders’. Am J Psychiatry 1992; 149: 240–4PubMedGoogle Scholar
  104. 104.
    Dawe B, Procter A, Philpot M. Concepts of memory impairment in the elderly and their relationship to dementia — a review. Int J Geriatr Psychiatry 1992; 7: 473–9Google Scholar
  105. 105.
    Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962; 86: 257–60PubMedGoogle Scholar
  106. 106.
    Ferris SH, Flicker C, Reisberg B, et al. Age-associated memory impairment, benign forgetfulness and dementia. In: Bergener M, Reisberg B, editors. Diagnosis and treatment of senile dementia. Berlin: Springer Verlag, 1989: 72–82Google Scholar
  107. 107.
    McEntee WJ, Crook TH. Age-associated memory impairment: a role for catecholamines. Neurology 1990; 40: 526–30PubMedGoogle Scholar
  108. 108.
    Derouesné C, Kalafat M, Guez D, et al. The age-associated memory impairment construct revisited. Int J Geriatr Psychiatry 1994; 9: 577–87Google Scholar
  109. 109.
    Popkin MK, Tucker G, Caine E, et al. The fate of organic mental disorders in DSM-VI: a progress report. Psychosomatic s 1989; 30: 438–41Google Scholar
  110. 110.
    Spitzer R, Williams JBW, First M. A proposal for DSM-IV: solving the ‘organic-nonorganic’ problem. J Neuropsychiatry Clin Neurosci 1989; 1(2): 126–27PubMedGoogle Scholar
  111. 111.
    Forette F, Henry J, Orgogozo J. Reliability of clinical criterion for the diagnosis of dementia. Arch Neurol 1989; 46: 646–8PubMedGoogle Scholar
  112. 112.
    Huff FJ, Becker JT, Belle SH, et al. Cognitive deficits and clinical diagnosis of Alzheimer’s disease. Neurology 1987; 37: 1119–24PubMedGoogle Scholar
  113. 113.
    Nielsen H, Lolk A, Pedersen I, et al. The accuracy of early diagnosis and predictors of death in Alzheimer’s disease and vascular dementia — a follow-up study. Acta Psychiatr Scand 1991; 84: 277–82PubMedGoogle Scholar
  114. 114.
    Burke WJ, Miller JP, Rubin EH, et al. The reliability of the Washington University Clinical Dementia Rating. Arch Neurol 1988; 45: 31–2PubMedGoogle Scholar
  115. 115.
    Berg L, Miller JP, Baty J, et al. Mild senile dementia of the Alzheimer type. 3. Longitudinal and cross-sectional assessment. Ann Neurol 1990; 28: 648–52PubMedGoogle Scholar
  116. 116.
    Roth M, Huppert FA, Tym E, et al. CAMDEX: the Cambridge examination for mental disorders of the elderly. Cambridge: University Press, 1988Google Scholar
  117. 117.
    O’Connor D, Pollit PA, Hyde JB, et al. Clinical issues relating to the diagnosis of mild dementia in a British community survey. Arch Neurol 1991; 48: 530–4PubMedGoogle Scholar
  118. 118.
    O’Connor DW, Pollit PA, Hyde JB, et al. A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the elderly examination. Acta Psychiatr Scand 1990; 81: 78–82PubMedGoogle Scholar
  119. 119.
    Fratiglioni FY, Grut M, Viitanen GM, et al. Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating scale. Acta Psychiatr Scand 1992; 86:49–54PubMedGoogle Scholar
  120. 120.
    Mowry BJ, Burvill PW. A study of mild dementia in the community using a wide range of diagnostic criterion. Br J Psychiatry 1988; 153: 328–34PubMedGoogle Scholar
  121. 121.
    Hultsch DF, Hertzog C, Dixon RA, et al. Memory self-knowledge and self-efficacy in the aged. In: Lowe ML, Brainerd CJ, editors. Cognitive development in adulthood: progress in cognitive developmental research. New York: Springer Verlag, 1988: 65–92Google Scholar
  122. 122.
    Shimamura AP, Squire LR. Memory and metamemory: a study of the feeling-of-knowing phenomenon in amnestic patients. J Exp Psychol 1986; 12: 452–60Google Scholar
  123. 123.
    Sunderland A, Watts K, Baddeley AD, et al. Subjective memory assessment and test performance in elderly adults. J Gerontol 1986; 41: 376–84PubMedGoogle Scholar
  124. 124.
    Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic: a three year prospective study. Arch Neurol 1985; 42: 894–6PubMedGoogle Scholar
  125. 125.
    Welsh K, Butters N, Hughes J, et al. Detection of abnormal memory decline in mild cases of Alzheimer’s disease using CERAD neuropsychological measures. Arch Neurol 1991; 48: 278–81PubMedGoogle Scholar
  126. 126.
    Berrios GE. Non-cognitive symptoms and the diagnosis of dementia: history and clinical aspects. Br J Psychiatry 1989; 154 Suppl. 4: 11–6Google Scholar
  127. 127.
    Folstein MF, Bijlsma PW. Noncognitive symptoms of Alzheimer’s disease. In: Terry R, Katzman R, Bick K, editors. Alzheimer disease. New York: Raven Press, 1994: 27–40Google Scholar
  128. 128.
    Rabins PV. Noncognitive symptoms in Alzheimer’s disease: definitions, treatments and possible etiologies. In: Terry R, Katzman R, Bick K, editors. Alzheimer disease. New York: Raven Press, 1994: 419–30Google Scholar
  129. 129.
    Brayne C, Calloway P. Normal ageing, impaired cognitive function, and senile dementia of the Alzheimer’s type: a continuum? Lancet 1988; i(8597): 1265–7Google Scholar
  130. 130.
    Kiloh LG. Pseudodementia. Acta Psychiatr Scand 1961; 37: 336–51PubMedGoogle Scholar
  131. 131.
    Kral VA, Emery O. Long term follow-up of depressive pseudodementia. Can J Psychiatry 1989; 34: 445–7PubMedGoogle Scholar
  132. 132.
    Roberts JKA. Differential diagnosis in neuropsychiatry. Chichester: Wiley & Sons, 1984Google Scholar
  133. 133.
    LaRue A, Watson J, Plotkin DA. First symptoms of dementia: a study of relatives’ reports. Int J Geriatr Psychiatry 1993; 8: 239–45Google Scholar
  134. 134.
    Katzman R, Aronson M, Fuld P, et al. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989; 25: 317–24PubMedGoogle Scholar
  135. 135.
    Crystal H, Dickson D, Fuld P, et al. Clinico-pathological studies in dementia: nondemented subjects with pathologically confirmed Alzheimer’s disease. Neurology 1988; 38: 1682–7PubMedGoogle Scholar
  136. 136.
    Amaducci L, Fratiglioni L. Epidemiology of AD: impact on the treatment. In: Giacobini E, Becker RE, editors. Alzheimer’s disease: therapeutic strategies. Basel: Birkhäuser Verlag, 1994: 8–16Google Scholar
  137. 137.
    Katzman R, Kawas CH. The epidemiology of dementia and Alzhmeimer’s disease. In: Terry R, Katzman R, Bick K, editors. Alzheimer disease. New York: Raven Press, 1994: 105–22Google Scholar
  138. 138.
    Fenn H, Luby V, Yesavage JA. Subtypes in Alzheimer’s disease and the impact of excess disability: recent findings. Int J Geriatr Psychiatry 1993; 8: 67–73Google Scholar
  139. 139.
    Ritchie K, Touchon J. Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical subtypes? J Clin Epidemiol 1992; 45: 1391–8PubMedGoogle Scholar
  140. 140.
    Corder E, Sauders A, Strittmaier W, et al. Gene dose of apolipoprotein E Type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261: 921–3PubMedGoogle Scholar
  141. 141.
    Scinto LFM, Daffner KM, Dressier D, et al. A potential noninvasive neurobiological test for Alzheimer’s disease. Science 1994; 266: 1051–4PubMedGoogle Scholar
  142. 142.
    Food and Drug Administration. Tacrine as a treatment for Alzheimer’s Dementia. An interim report from the FDA. N Engl J Med 1991; 324: 349–52Google Scholar
  143. 143.
    Giacobini E, Becker R. Development of drugs for Alzheimer therapy: a decade of progress. In: Giacobini E, Becker RE, editors. Alzheimer’s disease: therapeutic strategies. Basel: Birkhäuser Verlag, 1994: 1–7Google Scholar
  144. 144.
    Wolkowitz OM, Tinklenberg JR, Weingartner HA. Psychopharmacological perspective of cognitive functions. Neuropsychobiology 1985; 14: 88–96PubMedGoogle Scholar
  145. 145.
    Corkin S, Growdon JH, Sullivan EV, et al. Assessing treatment effects: a neuropsychological battery. In: Poon LW, editor. Handbook for clinical memory assessment of older adults. Washington: American Psychological Association, 1986: 156–7Google Scholar
  146. 146.
    Tyrell P, Hardy J, Rosor M. Tetrahydroaminoacridine and Alzheimer’s disease. Lancet 1987; i(8530): 444–5Google Scholar
  147. 147.
    Jansen KLR. Is treating memory impairment in Alzheimer’s disease an objective? Trends Neurosci 1988; 11: 210PubMedGoogle Scholar
  148. 148.
    Weinstein HC, Teunisse S, Van Gool WA. Tetrahydroamineacridine and lecithine in treatment of Alzheimer’s disease: effect on cognition, functioning in daily life, behavioral disturbances and burden experienced by the carers. J Neurol 1991; 238: 34–8PubMedGoogle Scholar
  149. 149.
    Crook T. Pharmacotherapy of cognitive deficits in Alzheimer’s disease and age associated memory impairment. Psychopharmacol Bull 1988; 24: 31–8PubMedGoogle Scholar
  150. 150.
    Brand N, Jolles J. Information processing in depression and anxiety. Psychol Med 1987; 17(1): 145–53PubMedGoogle Scholar
  151. 151.
    Nilsson LG, Backman L, Karlsson T. Priming and cued recall in elderly, alcohol intoxicated and sleep deprived subjects: a case of functionally similar memory deficits. Psychol Med 1989; 19(2): 423–33PubMedGoogle Scholar
  152. 152.
    Riedel WJ, Van Praag HM. Avoiding and managing anticholinergic effects of antidepressants. CNS Drugs 1995; 3(4): 245–59Google Scholar
  153. 153.
    Lister RG. The effects of benzodiazepines and 5-HT1A agonists on learning and memory. In: Rodgers RJ, Cooper SJ, editors. 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines. Chichester: Wiley, 1991: 267–80Google Scholar
  154. 154.
    Gaillard AWK, Gruisen A, De Jong R. The Influence of antihistamines on human performance. Eur J Clin Pharmacol 1988; 35(3): 249–54PubMedGoogle Scholar
  155. 155.
    Ramaekers JG, O’Hanlon JF. Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. Eur J Clin Pharmacol 1994; 47(3): 261–6PubMedGoogle Scholar
  156. 156.
    Jones RW, Wesnes KA, Kirby J. Effects of NMDA modulation in scopolamine dementia. Ann NY Acad Sci 1991; 640:241–4PubMedGoogle Scholar
  157. 157.
    Molchan SE, Mellow AM, Lawlor BA, et al. TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacol 1990; 100(1): 84–9Google Scholar
  158. 158.
    Preston GC, Ward C, Lines CR, et al. Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. Psychopharmacology 1989; 98(4): 487–94PubMedGoogle Scholar
  159. 159.
    Wesnes K, Jones RW, Kirby J. The effects of D-cycloserine, a glycine agonist, in a human model of the cognitive deficits associated with ageing and dementia. Br J Clin Pharmacol 1991; 31: 577–8Google Scholar
  160. 160.
    Preda L, Alberoni M, Bressi S, et al. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia. Psychopharmacology 1993; 110(4): 421–6PubMedGoogle Scholar
  161. 161.
    Wesnes KA, Anand R, Simpson PM, et al. The use of a scopolamine model to study the potential nootropic effects of aniracetam and piracetam in healthy volunteers. J Psychopharmacol 1990; 4(4): 219–32PubMedGoogle Scholar
  162. 162.
    Riedel WJ, Hogervorst E, Leboux RLAM, et al. Caffeine attenuates scopolamine-induced memory impairment in humans. Psychopharmacology. In pressGoogle Scholar
  163. 163.
    Rusted J, Eaton-Williams P. Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall. Psychopharmacology 1991; 104(3): 363–6PubMedGoogle Scholar
  164. 164.
    Wesnes K, Revell A. The separate and combined effects of scopolamine and nicotine on human information processing. Psychopharmacology 1984; 84(1): 5–11PubMedGoogle Scholar
  165. 165.
    Rush CR, Higgins ST, Hughes JR, et al. Acute behavioral effects of triazolam and caffeine, alone and in combination, in humans. Exp Clin Psychopharmacol 1994; 2(3): 211–22Google Scholar
  166. 166.
    Hasenfratz M, Bunge A, Dal Pra G, et al. Antagonistic effects of caffeine and alcohol on mental performance parameters. Pharmacol Biochem Behav 1993; 46(2): 463–5PubMedGoogle Scholar
  167. 167.
    Jarvis M. Does caffeine intake enhance absolute levels of cognitive performance? Psychopharmacology 1993; 110: 45–52PubMedGoogle Scholar
  168. 168.
    Wesnes K, Parrott A. Smoking, nicotine and human performance. Handbook of human performance. London: Academic Press, 1992: 127–67Google Scholar
  169. 169.
    Van Duijn M, Hofman A. Relation between nicotine intake and Alzheimer’s disease. BMJ 1991; 302: 1491–4PubMedGoogle Scholar
  170. 170.
    Meador KJ, Nichols ME, Franke P, et al. Evidence for a central cholinergic effect of high-dose thiamine. Ann Neurol 1993; 34(5): 724–6PubMedGoogle Scholar
  171. 171.
    Deijen JB, Van der Beek EJ, Orlebeke JF, et al. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology 1992; 109(4): 489–96PubMedGoogle Scholar
  172. 172.
    Bohnen N, Jolies J, Degenaar CP. Lower blood levels of vitamin B12 are related to decreased performance of healthy subjects in the Stroop Color Word Test. Neurosci Res Commun 1992; 11(1): 53–6Google Scholar
  173. 173.
    Bohnen N, Jolies J, Degenaar CP. Levels of trace elements in blood in healthy ageing subjects. Z Gerontol 1994; 27: 324–7PubMedGoogle Scholar
  174. 174.
    Jolies J, Houx PJ, Vreeling FW, et al. Biological risk factors for accelerated cognitive aging and dementia: findings from a multiple cohort study. Neurobiol Aging 1990; 11(3): 293Google Scholar
  175. 175.
    Riedel WJ, Jolies J. Decreased blood level of zinc: does it explain age-associated-memory-impairment? Neuropsychopharmacology 1993; 9 (2 Suppl.): 57Google Scholar
  176. 176.
    Levy R. Aging-associated cognitive decline: working party of the International Psychogeriatric Association in collaboration with WHO. Int Psychogeriatr 1994; 6: 63–8PubMedGoogle Scholar

Copyright information

© Adis International Limited 1995

Authors and Affiliations

  • J. Jolles
    • 1
  • F. R. J. Verhey
    • 1
  • W. J. Riedel
    • 1
  • P. J. Houx
    • 1
  1. 1.Maastricht Brain and Behaviour Institute, and Department of Psychiatry and Neuropsychology, Section of NeuropsychologyLimburg UniversityMD MaastrichtThe Netherlands

Personalised recommendations